ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 21 filers reported holding ELIEM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,952 | -1.8% | 66,626 | +4.1% | 0.00% | – |
| Q2 2023 | $179,239 | -3.4% | 64,014 | 0.0% | 0.00% | – |
| Q1 2023 | $185,640 | +80965.5% | 64,014 | 0.0% | 0.00% | – |
| Q4 2022 | $229 | -99.9% | 64,014 | -0.2% | 0.00% | – |
| Q3 2022 | $207,000 | +7.3% | 64,139 | 0.0% | 0.00% | – |
| Q2 2022 | $193,000 | -79.6% | 64,139 | -43.3% | 0.00% | – |
| Q1 2022 | $948,000 | -21.6% | 113,021 | -2.3% | 0.00% | – |
| Q4 2021 | $1,209,000 | -12.5% | 115,672 | +50.4% | 0.00% | – |
| Q3 2021 | $1,382,000 | – | 76,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,938,263 | $5,097,632 | 4.68% |
| RA Capital Management | 13,150,849 | $34,586,733 | 0.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 121,110 | $318,519 | 0.10% |
| Atom Investors LP | 78,886 | $207,470 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | $2,134,718 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $145,789 | 0.00% |
| Chicago Partners Investment Group LLC | 12,806 | $32,785 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,704 | $78,122 | 0.00% |
| NORTHERN TRUST CORP | 11,182 | $29,409 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |